Business

July 7, 2014 11:03 AM

BioDelivery Sciences shares rise on positive drug trial results

BioDelivery Sciences International shares were up nearly 15 percent in early trading Monday after the Raleigh company announced positive Phase 3 clinical trial results for its experimental treatment for chronic pain.

Related content

Comments